BNP Paribas Financial Markets’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.9M Buy
128,634
+86,059
+202% +$28.1M 0.02% 506
2025
Q1
$11.5M Buy
42,575
+857
+2% +$231K 0.01% 950
2024
Q4
$9.82M Sell
41,718
-73,066
-64% -$17.2M 0.01% 942
2024
Q3
$31.6M Sell
114,784
-11,228
-9% -$3.09M 0.02% 479
2024
Q2
$30.6M Buy
126,012
+24,566
+24% +$5.97M 0.03% 441
2024
Q1
$15.2M Buy
101,446
+18,742
+23% +$2.8M 0.01% 644
2023
Q4
$15.8M Buy
82,704
+31,301
+61% +$5.99M 0.02% 551
2023
Q3
$9.1M Buy
51,403
+12,822
+33% +$2.27M 0.01% 645
2023
Q2
$7.33M Sell
38,581
-32,502
-46% -$6.17M 0.01% 746
2023
Q1
$14.2M Buy
71,083
+42,972
+153% +$8.61M 0.02% 528
2022
Q4
$6.68M Sell
28,111
-61,239
-69% -$14.6M 0.01% 807
2022
Q3
$17.9M Buy
89,350
+32,229
+56% +$6.45M 0.03% 456
2022
Q2
$8.33M Sell
57,121
-9,579
-14% -$1.4M 0.01% 702
2022
Q1
$10.9M Buy
66,700
+681
+1% +$111K 0.01% 628
2021
Q4
$11.2M Sell
66,019
-11,162
-14% -$1.89M 0.02% 631
2021
Q3
$14.6M Buy
77,181
+57,144
+285% +$10.8M 0.02% 505
2021
Q2
$3.4M Sell
20,037
-3,958
-16% -$671K ﹤0.01% 1103
2021
Q1
$3.39M Sell
23,995
-14,050
-37% -$1.98M 0.01% 1027
2020
Q4
$4.94M Buy
38,045
+1,184
+3% +$154K 0.01% 770
2020
Q3
$5.37M Sell
36,861
-14,099
-28% -$2.05M 0.01% 756
2020
Q2
$7.55M Sell
50,960
-4,209
-8% -$623K 0.01% 590
2020
Q1
$6.01M Sell
55,169
-27,553
-33% -$3M 0.01% 632
2019
Q4
$9.53M Buy
82,722
+36,448
+79% +$4.2M 0.02% 568
2019
Q3
$3.72M Sell
46,274
-1,681
-4% -$135K 0.01% 819
2019
Q2
$3.48M Buy
47,955
+9,884
+26% +$717K 0.01% 814
2019
Q1
$3.56M Sell
38,071
-3,898
-9% -$364K 0.01% 766
2018
Q4
$3.06M Buy
41,969
+14,163
+51% +$1.03M 0.01% 717
2018
Q3
$2.43M Buy
27,806
+9,562
+52% +$837K ﹤0.01% 968
2018
Q2
$1.8M Buy
18,244
+2,870
+19% +$283K ﹤0.01% 1046
2018
Q1
$1.83M Buy
15,374
+3,298
+27% +$393K ﹤0.01% 1011
2017
Q4
$1.53M Buy
12,076
+2,579
+27% +$328K ﹤0.01% 1153
2017
Q3
$1.12M Sell
9,497
-3,503
-27% -$412K ﹤0.01% 1346
2017
Q2
$1.04M Sell
13,000
-2,043
-14% -$163K ﹤0.01% 1350
2017
Q1
$771K Sell
15,043
-728
-5% -$37.3K ﹤0.01% 1292
2016
Q4
$590K Buy
15,771
+5,231
+50% +$196K ﹤0.01% 1365
2016
Q3
$714K Sell
10,540
-586
-5% -$39.7K ﹤0.01% 1046
2016
Q2
$617K Buy
11,126
+2,156
+24% +$120K ﹤0.01% 1403
2016
Q1
$563K Sell
8,970
-6,660
-43% -$418K ﹤0.01% 1169
2015
Q4
$1.47M Buy
15,630
+4,847
+45% +$456K ﹤0.01% 1009
2015
Q3
$867K Sell
10,783
-78,631
-88% -$6.32M ﹤0.01% 1093
2015
Q2
$10.7M Buy
89,414
+85,127
+1,986% +$10.2M 0.03% 346
2015
Q1
$448K Buy
4,287
+2,223
+108% +$232K ﹤0.01% 1351
2014
Q4
$200K Buy
2,064
+64
+3% +$6.21K ﹤0.01% 1359
2014
Q3
$156K Sell
2,000
-134
-6% -$10.5K ﹤0.01% 1655
2014
Q2
$135K Buy
2,134
+1,134
+113% +$71.6K ﹤0.01% 1585
2014
Q1
$49.5K Buy
1,000
+246
+33% +$12.2K ﹤0.01% 1783
2013
Q4
$48.5K Sell
754
-15,205
-95% -$978K ﹤0.01% 1565
2013
Q3
$1.02M Sell
15,959
-4,443
-22% -$284K ﹤0.01% 971
2013
Q2
$633K Buy
+20,402
New +$633K ﹤0.01% 1137